Royal Philips (NYSE:PHG) reported quarterly earnings of €0.25 per share. This is a 37.5 percent decrease over earnings of €0.40 per share from the same period last year. The company reported €4.31 billion in sales this quarter. This is a 3.71 percent increase over sales of €4.16 billion the same period last year.
FDA Approves Merck’s Pneumococcal Vaccine As First Shot Designed For Adults
The FDA has approved Merck's Capvaxive, the first pneumococcal conjugate vaccine for adults, protecting against 21 strains of bacteria. Additionally, Merck's Keytruda received FDA approval for advanced endometrial carcinoma.
